For help on how to get the results you want, see our search tips.
73 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Spinraza (updated)
nusinersen sodium, Muscular Atrophy, Spinal
Date of authorisation: 30/05/2017,
, 
, 
, Revision: 8, Authorised, Last updated: 19/09/2019
-
List item
Human medicine European public assessment report (EPAR): Empliciti (updated)
Elotuzumab, Multiple Myeloma
Date of authorisation: 11/05/2016,, , Revision: 4, Authorised, Last updated: 18/09/2019
-
List item
Human medicine European public assessment report (EPAR): Ketoconazole HRA (updated)
Ketoconazole, Cushing Syndrome
Date of authorisation: 18/11/2014,, , , Revision: 9, Authorised, Last updated: 18/09/2019
-
List item
Human medicine European public assessment report (EPAR): Ofev (updated)
nintedanib, Idiopathic Pulmonary Fibrosis
Date of authorisation: 14/01/2015,, , , Revision: 10, Authorised, Last updated: 13/09/2019
-
List item
Human medicine European public assessment report (EPAR): Firdapse (previously Zenas) (updated)
amifampridine, Lambert-Eaton Myasthenic Syndrome
Date of authorisation: 23/12/2009,, , 
, Revision: 17, Authorised, Last updated: 13/09/2019
-
List item
Human medicine European public assessment report (EPAR): Soliris (updated)
Eculizumab, Hemoglobinuria, Paroxysmal
Date of authorisation: 20/06/2007,, , Revision: 26, Authorised, Last updated: 04/09/2019
-
List item
Human medicine European public assessment report (EPAR): Lartruvo (updated)
Olaratumab, Sarcoma
Date of authorisation: 09/11/2016,
, , , , 
, Revision: 3, Withdrawn, Last updated: 02/09/2019
-
List item
Human medicine European public assessment report (EPAR): Sovaldi (updated)
Sofosbuvir, Hepatitis C, Chronic
Date of authorisation: 16/01/2014,, , Revision: 18, Authorised, Last updated: 30/08/2019
-
List item
Human medicine European public assessment report (EPAR): Maviret (updated)
glecaprevir / pibrentasvir, Hepatitis C, Chronic
Date of authorisation: 26/07/2017,, , Revision: 7, Authorised, Last updated: 30/08/2019
-
List item
Human medicine European public assessment report (EPAR): Daklinza (updated)
daclatasvir dihydrochloride, Hepatitis C, Chronic
Date of authorisation: 22/08/2014,, , Revision: 15, Withdrawn, Last updated: 30/08/2019
-
List item
Human medicine European public assessment report (EPAR): Imvanex (updated)
modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus, Smallpox Vaccine
Date of authorisation: 31/07/2013,, , Revision: 14, Authorised, Last updated: 28/08/2019
-
List item
Human medicine European public assessment report (EPAR): Lojuxta
Lomitapide, Hypercholesterolemia
Date of authorisation: 31/07/2013,, , Revision: 11, Authorised, Last updated: 23/08/2019
-
List item
Human medicine European public assessment report (EPAR): Onpattro
patisiran sodium, Amyloidosis, Familial
Date of authorisation: 27/08/2018,, , , Revision: 3, Authorised, Last updated: 22/08/2019
-
List item
Human medicine European public assessment report (EPAR): Vedrop
tocofersolan, Cholestasis, Vitamin E Deficiency
Date of authorisation: 23/07/2009,, , Revision: 13, Authorised, Last updated: 22/08/2019
-
List item
Human medicine European public assessment report (EPAR): Kalydeco
ivacaftor, Cystic Fibrosis
Date of authorisation: 22/07/2012,, , Revision: 18, Authorised, Last updated: 20/08/2019
-
List item
Human medicine European public assessment report (EPAR): Sylvant
siltuximab, Giant Lymph Node Hyperplasia
Date of authorisation: 22/05/2014,, , , Revision: 9, Authorised, Last updated: 20/08/2019
-
List item
Human medicine European public assessment report (EPAR): Darzalex
Daratumumab, Multiple Myeloma
Date of authorisation: 28/04/2017,, , , Revision: 9, Authorised, Last updated: 19/08/2019
-
List item
Human medicine European public assessment report (EPAR): Naglazyme
galsulfase, Mucopolysaccharidosis VI
Date of authorisation: 23/01/2006,, , , Revision: 14, Authorised, Last updated: 14/08/2019
-
List item
Human medicine European public assessment report (EPAR): Strensiq
asfotase alfa, Hypophosphatasia
Date of authorisation: 28/08/2015,, , , Revision: 9, Authorised, Last updated: 13/08/2019
-
List item
Human medicine European public assessment report (EPAR): Kanuma
sebelipase alfa, Lipid Metabolism, Inborn Errors
Date of authorisation: 28/08/2015,, , , Revision: 3, Authorised, Last updated: 07/08/2019
-
List item
Human medicine European public assessment report (EPAR): Harvoni
ledipasvir 90 mg, sofosbuvir 400 mg, Hepatitis C, Chronic
Date of authorisation: 17/11/2014,, , Revision: 17, Authorised, Last updated: 05/08/2019
-
List item
Human medicine European public assessment report (EPAR): Kisplyx
lenvatinib mesilate, Carcinoma, Renal Cell
Date of authorisation: 25/08/2016,, , Revision: 9, Authorised, Last updated: 01/08/2019
-
List item
Human medicine European public assessment report (EPAR): Defitelio
defibrotide, Hepatic Veno-Occlusive Disease
Date of authorisation: 18/10/2013,, , , Revision: 9, Authorised, Last updated: 31/07/2019
-
List item
Human medicine European public assessment report (EPAR): Lenvima
lenvatinib mesylate, Thyroid Neoplasms
Date of authorisation: 28/05/2015,, , Revision: 8, Authorised, Last updated: 31/07/2019
-
List item
Human medicine European public assessment report (EPAR): Prepandrix
A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2), Influenza, Human, Immunization, Disease Outbreaks
Date of authorisation: 14/05/2008,, Revision: 13, Authorised, Last updated: 26/07/2019